RIBOSPHERE

Welcome to the Brand page for “RIBOSPHERE”, which is offered here for Chemical preparations for medical and veterinary purposes for the treatment and prevention of cancerous diseases, autoimmune disorders, genetic defects or metabolic disorders; medical and pharmaceutical preparations comprising liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions for the treatment and prevention of cancerous diseases, autoimmune disorders, genetic defects or metabolic disorders; medical and pharmaceutical preparations comprising, in particular, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and comprising additional active ingredients, in particular proteins or nucleic acids for the treatment and prevention of cancerous diseases, autoimmune disorders, genetic defects or metabolic disorders; carriers and carrier systems, drug delivery agents in the form of powders, tablets, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and capsules that provide controlled release of active ingredients for pharmaceuticals for use in the treatment of cancer, autoimmune disorders, genetic defects, and metabolic disorders;.

Its status is currently believed to be active. Its class is unavailable. “RIBOSPHERE” is believed to be currently owned by “BioNTech SE”.